# Marblegate Capital Corp: financial statements, quarterly

MGTE · OTC · CIK 1965052 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgte.md) · [Financials](/companies/mgte/financials.md) · [Filings](/companies/mgte/filings.md) · [Insiders](/companies/mgte/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgte/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [5.1](/filings/0000950170-25-109084.md) | [5.4](/filings/0001193125-25-278207.md) | [5.0 d](/filings/0001193125-26-125186.md) | [4.6](/filings/0001193125-26-224163.md) | [17.8](/filings/0001193125-26-349672.md) | [12.0](/filings/0001193125-25-278207.md) | [14.2 d](/filings/0001193125-26-125186.md) | [14.1](/filings/0001193125-26-224163.md) | [16.7](/filings/0001193125-26-349672.md) |
| Operating income | $m | [0.0](/filings/0000950170-25-072547.md) | [1.2](/filings/0000950170-25-109084.md) | [1.8](/filings/0001193125-25-278207.md) | [1.1 d](/filings/0001193125-26-125186.md) | [(0.9)](/filings/0001193125-26-224163.md) | [3.6](/filings/0001193125-26-349672.md) | [(1.2)](/filings/0001193125-25-278207.md) | [(0.6) d](/filings/0001193125-26-125186.md) | [(3.5)](/filings/0001193125-26-224163.md) | [(4.3)](/filings/0001193125-26-349672.md) |
| Income tax | $m | not reported | [0.0](/filings/0000950170-25-109084.md) | [0.0](/filings/0001193125-25-278207.md) | [0.0 d](/filings/0001193125-26-125186.md) | [0.0](/filings/0001193125-26-224163.md) | [49.3](/filings/0001193125-26-349672.md) | [1.7](/filings/0001193125-25-278207.md) | [3.2 d](/filings/0001193125-26-125186.md) | [(2.9)](/filings/0001193125-26-224163.md) | [(0.6)](/filings/0001193125-26-349672.md) |
| Net income | $m | [0.0](/filings/0000950170-25-072547.md) | [2.5](/filings/0000950170-25-109084.md) | [9.0](/filings/0001193125-25-278207.md) | [(4.2) d](/filings/0001193125-26-125186.md) | [(3.7)](/filings/0001193125-26-224163.md) | [(48.0)](/filings/0001193125-26-349672.md) | [(1.7)](/filings/0001193125-25-278207.md) | [8.5 d](/filings/0001193125-26-125186.md) | [(1.2)](/filings/0001193125-26-224163.md) | [(4.3)](/filings/0001193125-26-349672.md) |
| Diluted EPS | $ per share | [0.00](/filings/0000950170-25-072547.md) | [0.04](/filings/0000950170-25-109084.md) | [0.14](/filings/0001193125-25-278207.md) | not reported | [(0.06)](/filings/0001193125-26-224163.md) | [(0.65)](/filings/0001193125-26-349672.md) | [(0.02)](/filings/0001193125-25-278207.md) | not reported | [(0.02)](/filings/0001193125-26-224163.md) | [(0.06)](/filings/0001193125-26-349672.md) |
| Basic EPS | $ per share | [0.00](/filings/0000950170-25-072547.md) | [0.04](/filings/0000950170-25-109084.md) | [0.14](/filings/0001193125-25-278207.md) | not reported | [(0.06)](/filings/0001193125-26-224163.md) | [(0.65)](/filings/0001193125-26-349672.md) | [(0.02)](/filings/0001193125-25-278207.md) | not reported | [(0.02)](/filings/0001193125-26-224163.md) | [(0.06)](/filings/0001193125-26-349672.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [35.2](/filings/0001193125-26-125186.md) | not reported | [13.3](/filings/0000950170-25-109084.md) | [10.6](/filings/0001193125-25-278207.md) | [25.3](/filings/0001193125-26-349672.md) | [5.5](/filings/0001193125-26-224163.md) | [7.3](/filings/0001193125-26-349672.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [36.6](/filings/0001193125-26-125186.md) | not reported | [23.3](/filings/0000950170-25-109084.md) | [21.6](/filings/0001193125-25-278207.md) | [37.2](/filings/0001193125-26-349672.md) | [21.7](/filings/0001193125-26-224163.md) | [21.7](/filings/0001193125-26-349672.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [673](/filings/0001193125-26-125186.md) | [0.0](/filings/0000950170-25-072547.md) | [660](/filings/0000950170-25-109084.md) | [664](/filings/0001193125-25-278207.md) | [713](/filings/0001193125-26-349672.md) | [706](/filings/0001193125-26-224163.md) | [705](/filings/0001193125-26-349672.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [9.9](/filings/0001193125-26-125186.md) | not reported | [12.7](/filings/0000950170-25-109084.md) | [15.6](/filings/0001193125-25-278207.md) | [19.0](/filings/0001193125-26-349672.md) | [18.9](/filings/0001193125-26-224163.md) | [15.7](/filings/0001193125-26-349672.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [14.6](/filings/0001193125-26-125186.md) | [0.2](/filings/0000950170-25-072547.md) | [67.6](/filings/0000950170-25-109084.md) | [72.4](/filings/0001193125-25-278207.md) | [117](/filings/0001193125-26-349672.md) | [113](/filings/0001193125-26-224163.md) | [117](/filings/0001193125-26-349672.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-125186.md) | not reported | not reported | not reported | [37.2](/filings/0001193125-26-349672.md) | [35.8](/filings/0001193125-26-224163.md) | [44.0](/filings/0001193125-26-349672.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-125186.md) | not reported | not reported | not reported | [4.8](/filings/0001193125-26-349672.md) | [4.9](/filings/0001193125-26-224163.md) | [5.5](/filings/0001193125-26-349672.md) |
| Shareholders' equity | $m | [(0.0)](/filings/0000950170-25-072547.md) | [(0.0)](/filings/0000950170-25-072547.md) | [661](/filings/0001193125-25-278207.md) | [670](/filings/0001193125-25-278207.md) | [658](/filings/0001193125-26-125186.md) | [(0.2)](/filings/0000950170-25-072547.md) | [485](/filings/0000950170-25-109084.md) | [483](/filings/0001193125-25-278207.md) | [492](/filings/0001193125-26-349672.md) | [491](/filings/0001193125-26-224163.md) | [486](/filings/0001193125-26-349672.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000950170-25-072547.md) | [6.4 d](/filings/0000950170-25-109084.md) | [3.5 d](/filings/0001193125-25-278207.md) | [0.4 d](/filings/0001193125-26-125186.md) | [1.8](/filings/0001193125-26-224163.md) | [(4.7) d](/filings/0001193125-26-349672.md) | [1.7 d](/filings/0001193125-25-278207.md) | [2.3 d](/filings/0001193125-26-125186.md) | [(6.8)](/filings/0001193125-26-224163.md) | [(5.2) d](/filings/0001193125-26-349672.md) |
| Capital expenditure | $m | not reported | not reported | [0.3 d](/filings/0001193125-25-278207.md) | [(0.3) d](/filings/0001193125-26-125186.md) | [0.0](/filings/0001193125-26-224163.md) | [0.0 d](/filings/0001193125-26-349672.md) | [20.7 d](/filings/0001193125-25-278207.md) | [(20.5) d](/filings/0001193125-26-125186.md) | [0.1](/filings/0001193125-26-224163.md) | [0.0 d](/filings/0001193125-26-349672.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0000950170-25-072547.md) | [63.0](/filings/0000950170-25-109084.md) | [63.0](/filings/0001193125-25-278207.md) | [63.0](/filings/0001193125-26-224163.md) | [73.1](/filings/0001193125-26-349672.md) | [73.9](/filings/0001193125-25-278207.md) | [73.9](/filings/0001193125-26-224163.md) | [73.9](/filings/0001193125-26-349672.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 73,914,402 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349672.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.